UP Govt Unveils 9.5 Crore Plan With 20 Institutions For Pharma Growth
The Uttar Pradesh government has introduced its first-ever standard operating procedure (SOP) for the pharmaceutical sector, aiming to strengthen drug manufacturing and clinical research. This initiative is designed to position the state as a global pharma hub by streamlining production and clinical trial processes.
As part of the plan, 20 medical institutions across the state have been onboarded to conduct clinical trials. These institutions will follow globally aligned protocols and receive specialised training to ensure adherence to the best practices. A budget of ₹9.5 crore has been allocated to create a robust ecosystem for pharmaceutical innovation and testing.
The strategy also includes hosting conferences with experts, standardising resources for pharmaceutical counselling, and conducting Good Clinical Practices (GCP) training for doctors and researchers in selected colleges. Partnerships with prominent institutions such as THSTI, AKTU, and BIRAC will further enhance the sector’s capabilities.
This landmark move is expected to unlock new opportunities and address challenges faced by the state’s pharma industry.
2026-10-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal
-
Stahl Reopens Ranipet Plant
-
The Revenge of Titanium Dioxide: When a Ton of Pigment Ignites a Silent Uprising in China’s Chemical Industry
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
Japanese Plastics Market Accelerates its Shifts to Recycled Materials and Bioplastics
-
Triple Shield, Zero Risk: EFSA Declares Stacked GM Cotton Safe for Food, Feed, and Environment
-
Red Algae, Golden Promise—With a Daily Dose Warning: EFSA Clears Astaxanthin-Rich Algal Meal for New Foods
-
Arkema Divests PVC Additives Business to Focus Resources on High-Performance Materials Market
-
From Kitchen Herb to Feed Additive: EFSA Gives Green Light to Marjoram Oil—With a Caution for Handlers
-
From Fungus to Food: EFSA Greenlights Rhizomucor pusillus Biomass as Safe Novel Ingredient
Recommend Reading
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
US Imposes Heavy Duties on Chinese L-Lysine with Combined Rates up to 188%
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Polyvantis Opens Shanghai Technical Center
-
EU Finalizes Anti-Dumping Duties on BDO from China, with Rates up to 113.7%
-
Supply-Demand Dynamics Dominate Market Landscape; Formic Acid Prices Remain Stable with a Slight Increase
-
June Acetic Acid Market Trends: First Decline, Then Rise
-
Methanol Market Shows Narrow Fluctuations in China
-
Cyclohexane Market in Low Demand Season with High Inventory Levels
-
February 10 Isopropanol Market Remains Stable in China